Order byBest matchMost fresh
23andMe’s failure shows how risky it can be to invest in a SPAC
The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations.
23andMe money woes could expose killers who escaped justice: expert
The bankruptcy filing of 23andMe has sparked the potential for a sale that could be used to solve cold cases with the use of genetic testing.
23andMe collapse raises questions for California’s nation-leading privacy laws
California has some of the strongest privacy laws in the country — and the only dedicated privacy agency — but 23andMe has revealed the limits of legislation when the worst happens, with even the state attorney general admitting he struggled to delete his own data from the company.
Anne Wojcicki, the floundering 23andMe’s eternal optimist
Despite the company filing for bankruptcy, the co-founder won’t give up on her dream of using DNA kits to discover new drugs
Whit Johnson quitting 23andMe
After the company filed for bankruptcy state officials recommend customers delete their data making it a difficult decision for families.
A 23andMe cofounder says the company 'lost its way' under the last leaders
Me cofounder Linda Avey is mourning what the biotech company could have become. The company filed for Chapter 11 bankruptcy protection on Sunday.
Explore more
House Republican warns 23andMe and Trump administration to keep genetic data out of hands of ‘bad actors’
Rep. Stephanie Bice is sending letters to the Trump administration and 23andme to raise alarm bells about the security risks selling the information poses.
23andMe says it won permission from a judge to sell customers’ medical and ancestry data. Here’s how to delete yours
The company says that during bankruptcy, its security precautions concerning genetic data will remain the same, but its privacy policy says these measures can change at will.
Feedback